Hongju Wu

2001 University of Alabama, Birmingham, Birmingham, AL, United States 
"Hongju Wu"
Mean distance: 17.01 (cluster 59)


Sign in to add mentor
Craig C. Garner grad student 2001 UAB
 (Mechanisms that regulate protein interactions and subcellular distribution of synapse -associated protein SAP97.)


Sign in to add trainee
Yizhe Tang grad student 2005-2009 UAB
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Borovjagin AV, Dong J, Passineau MJ, et al. (2011) Adenovirus gene transfer to amelogenesis imperfecta ameloblast-like cells. Plos One. 6: e24281
Short JJ, Rivera AA, Wu H, et al. (2010) Substitution of adenovirus serotype 3 hexon onto a serotype 5 oncolytic adenovirus reduces factor X binding, decreases liver tropism, and improves antitumor efficacy. Molecular Cancer Therapeutics. 9: 2536-44
Matthews QL, Fatima A, Tang Y, et al. (2010) HIV antigen incorporation within adenovirus hexon hypervariable 2 for a novel HIV vaccine approach. Plos One. 5: e11815
Nash JE, Appleby VJ, Corrêa SA, et al. (2010) Disruption of the interaction between myosin VI and SAP97 is associated with a reduction in the number of AMPARs at hippocampal synapses. Journal of Neurochemistry. 112: 677-90
Tang Y, Wu H, Ugai H, et al. (2009) Derivation of a triple mosaic adenovirus for cancer gene therapy. Plos One. 4: e8526
Preuss MA, Glasgow JN, Everts M, et al. (2008) Enhanced Gene Delivery to Human Primary Endothelial Cells Using Tropism-Modified Adenovirus Vectors. The Open Gene Therapy Journal. 1: 7-11
Matthews QL, Yang P, Wu Q, et al. (2008) Optimization of capsid-incorporated antigens for a novel adenovirus vaccine approach. Virology Journal. 5: 98
Tang Y, Le LP, Matthews QL, et al. (2008) Derivation of a triple mosaic adenovirus based on modification of the minor capsid protein IX. Virology. 377: 391-400
Zhu ZB, Lu B, Park M, et al. (2008) Development of an optimized conditionally replicative adenoviral agent for ovarian cancer. International Journal of Oncology. 32: 1179-88
Wu H, Curiel DT. (2008) Fiber-modified adenoviruses for targeted gene therapy. Methods in Molecular Biology (Clifton, N.J.). 434: 113-32
See more...